AllyGPO Appoints Kurt Defenbaugh as President of AllyRetina
Seasoned retina operator to advance technology-forward services for rapidly growing membership. FRISCO, Texas, Jan. 23, 2026 /PRNewswire/ -- AllyGPO® today...
Day: January 23, 2026
Pair Team Announces Acquisition of Town Square to Expand Community-Connected Care for Medicare and Medicaid Beneficiaries
SAN FRANCISCO, Jan. 23, 2026 /PRNewswire/ -- Pair Team, an AI-enabled medical group for the safety net, today announced its acquisition...
Alcresta Therapeutics Announces Publication of Real-World Evidence Showing Improvements in Growth for Children Ages 1 to 5 Years Old With Use of RELiZORB®
Clinical data published in Nutrients highlights significant improvements in weight and body mass index (BMI) z-scores with use of RELiZORBWALTHAM,...
Analog Devices Appoints Yoky Matsuoka to its Board of Directors
WILMINGTON, Mass., Jan. 23, 2026 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI) today announced the appointment of Dr. Yoky Matsuoka to...
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation
Newest version of BD® Research Cloud features an AI-powered tool for automated panel design to improve quality, efficiency and usability...
Mentavi Health Presented Validation Data for Its Online Adult ADHD Diagnostic Evaluation at APSARD 2026
Mentavi Chief Medical Officer Barry K. Herman, MD, MMM, presented a poster summarizing Mentavi's recently published study in the Journal...
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
Toronto, Ontario--(Newsfile Corp. - January 23, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
Nalu Announces Publication of Results from COMFORT Randomized Controlled Trial (RCT) Demonstrating Sustained Pain Relief and Functional Improvements Over 24 Months
CARLSBAD, Calif.--(BUSINESS WIRE)--#COMFORT24--The 24-month results of the COMFORT Peripheral Nerve Stimulation (PNS) RCT were published on January 23, 2026 in...
Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit
HAMILTON, BERMUDA / ACCESS Newswire / January 23, 2026 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company...
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision...
BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema
RESEARCH TRIANGLE PARK, N.C., Jan. 23, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has completed...
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
Dallas, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that...
Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary
THE WOODLANDS, Texas, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will ring the...
Daxor Corporation Announces $9 Million Registered Direct Offering
OAK RIDGE, TN, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NasdaqCM: DXR) (“Daxor” or the “Company”) announced today that...
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
Voluntarily Delisting of Ordinary Shares from Trading on the Tel Aviv Stock Exchange to Promote U.S.-Based Trading, Reduce Administrative Costs...
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock
MALVERN, Pa., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a pioneering biotechnology leader in gene therapies for...
Aeroflow Health CEO Casey Hite Named to The Healthcare Technology Report’s Top Healthcare Technology CEOs of 2025 List
Casey Hite is recognized for his strategic leadership in advancing healthcare technology to provide patients with better access to careASHEVILLE,...
Adagene Provides Business Update and 2026 Objectives
Data update from the ongoing Phase 1b/2 study of muzastotug + pembrolizumab in 3L+ MSS CRC patients remains on track...
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
PHILADELPHIA, Pennsylvania and COPENHAGEN, Denmark, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Alveus Therapeutics, Inc. (“Alveus”), a clinical-stage biotechnology company developing...
AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026
DALLAS, Jan. 23, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss...